发明名称 Benzimidazolone histamine H3 antagonists
摘要 Disclosed are novel compounds of the formula wherein R<SUP>1 </SUP>is benzimidazolone derivative, M<SUP>1 </SUP>and M<SUP>2 </SUP>are optionally substituted carbon or nitrogen, R<SUP>2 </SUP>includes optionally substituted aryl or heteroaryl, and the remaining variables are as defined in the specification, and the remaining variables are as defined in the specification; also disclosed are pharmaceutical compositions comprising the compounds of formula I and methods of treating various diseases or conditions, such as allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of formula I, as well as methods of treating said diseases or conditions using the compounds of formula I in combination with an H<SUB>1 </SUB>receptor antagonist.
申请公布号 US7220735(B2) 申请公布日期 2007.05.22
申请号 US20030414943 申请日期 2003.04.16
申请人 SCHERING CORPORATION 发明人 TING PAULINE C.;ASLANIAN ROBERT G.;BERLIN MICHAEL Y.;BOYCE CHRISTOPHER W.;CAO JIANHUA;MANGIARACINA PIETRO;MCCORMICK KEVIN D.;MUTAHI MWANGI W.;ROSENBLUM STUART B.;SHIH NENG-YANG;SOLOMON DANIEL M.;TOM WING C.;ZENG QINGBEI
分类号 A61K31/495;C07D487/04;A61K31/4545;A61K31/501;A61K31/506;A61K31/517;A61K31/5377;A61P1/00;A61P3/04;A61P9/00;A61P9/02;A61P11/00;A61P11/02;A61P25/00;A61P25/06;A61P25/18;A61P25/20;A61P25/28;A61P37/08;C07D401/14;C07D405/14;C07D409/14;C07D413/14;C07D417/14;C07D471/04 主分类号 A61K31/495
代理机构 代理人
主权项
地址